Depixus logotype

This website uses cookies to ensure you get the best experience on our website.

Depixus and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking "Manage cookies" at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, which is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor
Depixus career site

Q&A about Depixus

  • Depixus was founded in 2012.

  • The average age of Depixus employees is 37.

  • The gender split at Depixus is 55% men and 45% women.

  • The Depixus team currently numbers 60 employees.

About Depixus

Depixus launches MAGNA™ - a unique technology for directly measuring the dynamic interactions of thousands of individual molecules in real time. Understanding these interactions is key to understanding health and disease, and finding more effective treatments. Obtaining more precise information about these interactions is essential for advancing our knowledge of biology and accelerating drug development.

Based on magnetic force spectroscopy, MAGNA™ is a revolutionary technology that will transform our understanding of life, health and disease. By revealing biomolecular interactions, it will decode disease mechanisms and unlock more effective therapies.


Founded in 2012
Co-workers 57